Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-MC: Immunosuppression in Virus Negative Myocarditis
NCT04654988Phase 4Active, not recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Dec 2022
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone, azathioprine in myocarditis, inflammatory cardiomyopathy, sponsored by Medical University of Warsaw. Started Dec 2022; status: active, not recruiting.
02
Drugs
prednisoneazathioprine
03
Conditions
myocarditisinflammatory cardiomyopathy
Beyond the preview
Go deeper on NCT04654988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04654988.